{"date":"2026-06-01","count":21,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-1799-2026-06-01-2059-igcmtj","company_id":"1799","company":"易威","market":"上櫃","industry":"生技醫療","date":"2026-06-01","time":"20:59:11","subject":"代孫公司江蘇華瀚醫藥科技有限公司公告HH-001沙庫巴曲纈沙坦鈉片藥品,諾華專利獲得中國大陸藥品專利期限補償,專利延長至2031年11月8日","clause":"第53款","fact_date":"2026-06-01","cite_as":"公開資訊觀測站重大訊息：易威（1799），2026-06-01 20:59，「代孫公司江蘇華瀚醫藥科技有限公司公告HH-001沙庫巴曲纈沙坦鈉片藥品,諾華專利獲得中國大陸藥品專利期限補償,專利延長至」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6838-2026-06-01-1905-1cfgj39","company_id":"6838","company":"台新藥","market":"上市","industry":"生技醫療","date":"2026-06-01","time":"19:05:44","subject":"本公司新藥APP13007 (BYQLOVI) 獲衛福部領證通知，核准適應症為治療眼科手術引起之疼痛與發炎","clause":"第10款","fact_date":"2026-06-01","cite_as":"公開資訊觀測站重大訊息：台新藥（6838），2026-06-01 19:05，「本公司新藥APP13007 (BYQLOVI) 獲衛福部領證通知，核准適應症為治療眼科手術引起之疼痛與發炎」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3176-2026-06-01-1900-zxewte","company_id":"3176","company":"基亞","market":"上櫃","industry":"生技醫療","date":"2026-06-01","time":"19:00:27","subject":"公告本公司累積處分有價證券達公告標準","clause":"第20款","fact_date":"2026-06-01","cite_as":"公開資訊觀測站重大訊息：基亞（3176），2026-06-01 19:00，「公告本公司累積處分有價證券達公告標準」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6610-2026-06-01-1852-1bgk8m9","company_id":"6610","company":"安成生技","market":"興櫃","industry":"生技醫療","date":"2026-06-01","time":"18:52:26","subject":"公告本公司用於治療圓禿之開發中新藥AC-1101，向衛生福利部食品藥物管理署（TFDA）提出申請進行第2a期人體臨床試驗。","clause":"第8款","fact_date":"2026-06-01","cite_as":"公開資訊觀測站重大訊息：安成生技（6610），2026-06-01 18:52，「公告本公司用於治療圓禿之開發中新藥AC-1101，向衛生福利部食品藥物管理署（TFDA）提出申請進行第2a期人體臨床試驗」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4114-2026-06-01-1816-1fnlvvb","company_id":"4114","company":"健喬","market":"上櫃","industry":"生技醫療","date":"2026-06-01","time":"18:16:05","subject":"本公司與輝瑞大藥廠（Pfizer)簽訂藥物經銷合約","clause":"第53款","fact_date":"2026-06-01","cite_as":"公開資訊觀測站重大訊息：健喬（4114），2026-06-01 18:16，「本公司與輝瑞大藥廠（Pfizer)簽訂藥物經銷合約」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4163-2026-06-01-1711-rxx7eg","company_id":"4163","company":"鐿鈦","market":"上櫃","industry":"生技醫療","date":"2026-06-01","time":"17:11:35","subject":"公告本公司註銷收回限制員工權利新股辦理變更登記完成","clause":"第36款","fact_date":"2026-06-01","cite_as":"公開資訊觀測站重大訊息：鐿鈦（4163），2026-06-01 17:11，「公告本公司註銷收回限制員工權利新股辦理變更登記完成」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6709-2026-06-01-1701-13pug1","company_id":"6709","company":"昱厚生技","market":"興櫃","industry":"生技醫療","date":"2026-06-01","time":"17:01:39","subject":"公告本公司115年現金增資全體董事放棄認購股數達得認購股數二分之一以上，並洽特定人認購事宜。","clause":"第37款","fact_date":"2026-06-01","cite_as":"公開資訊觀測站重大訊息：昱厚生技（6709），2026-06-01 17:01，「公告本公司115年現金增資全體董事放棄認購股數達得認購股數二分之一以上，並洽特定人認購事宜。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4147-2026-06-01-1606-l7fmyh","company_id":"4147","company":"中裕","market":"上櫃","industry":"生技醫療","date":"2026-06-01","time":"16:06:51","subject":"中裕新藥愛滋新藥 Trogarzo 台灣上市取得關鍵進展，合作夥伴友華生技取得 TFDA 品名核定","clause":"第53款","fact_date":"2026-06-01","cite_as":"公開資訊觀測站重大訊息：中裕（4147），2026-06-01 16:06，「中裕新藥愛滋新藥 Trogarzo 台灣上市取得關鍵進展，合作夥伴友華生技取得 TFDA 品名核定」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6535-2026-06-01-1600-5i25z4","company_id":"6535","company":"順藥","market":"上櫃","industry":"生技醫療","date":"2026-06-01","time":"16:00:29","subject":"公告本公司中國授權夥伴上海醫藥完成NMPA之二/三期臨床試驗諮詢","clause":"第53款","fact_date":"2026-06-01","cite_as":"公開資訊觀測站重大訊息：順藥（6535），2026-06-01 16:00，「公告本公司中國授權夥伴上海醫藥完成NMPA之二/三期臨床試驗諮詢」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6847-2026-06-01-1530-799p5r","company_id":"6847","company":"普瑞博","market":"興櫃","industry":"生技醫療","date":"2026-06-01","time":"15:30:07","subject":"公告本公司會計主管、公司治理主管異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：普瑞博（6847），2026-06-01 15:30，「公告本公司會計主管、公司治理主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7713-2026-06-01-1523-7rzr08","company_id":"7713","company":"威力德生醫","market":"上櫃","industry":"生技醫療","date":"2026-06-01","time":"15:23:37","subject":"公告本公司法人董事指派代表人","clause":"第6款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：威力德生醫（7713），2026-06-01 15:23，「公告本公司法人董事指派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6492-2026-06-01-1420-1nwix1l","company_id":"6492","company":"生華科","market":"上櫃","industry":"生技醫療","date":"2026-06-01","time":"14:20:26","subject":"公告本公司第二屆永續發展委員會委員","clause":"第6款","fact_date":"2026-06-01","cite_as":"公開資訊觀測站重大訊息：生華科（6492），2026-06-01 14:20，「公告本公司第二屆永續發展委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7561-2026-06-01-1407-io8xzp","company_id":"7561","company":"光晟生技","market":"興櫃","industry":"生技醫療","date":"2026-06-01","time":"14:07:34","subject":"本公司財務及會計主管異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：光晟生技（7561），2026-06-01 14:07，「本公司財務及會計主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7561-2026-06-01-1406-1pf7u8s","company_id":"7561","company":"光晟生技","market":"興櫃","industry":"生技醫療","date":"2026-06-01","time":"14:06:47","subject":"本公司發言人異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：光晟生技（7561），2026-06-01 14:06，「本公司發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6492-2026-06-01-1358-17vkp6y","company_id":"6492","company":"生華科","market":"上櫃","industry":"生技醫療","date":"2026-06-01","time":"13:58:49","subject":"公告本公司董事會委任薪資報酬委員會委員","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：生華科（6492），2026-06-01 13:58，「公告本公司董事會委任薪資報酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6492-2026-06-01-1355-1r2d1uw","company_id":"6492","company":"生華科","market":"上櫃","industry":"生技醫療","date":"2026-06-01","time":"13:55:31","subject":"公告本公司第三屆審計委員會委員","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：生華科（6492），2026-06-01 13:55，「公告本公司第三屆審計委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6492-2026-06-01-1352-s0kpz3","company_id":"6492","company":"生華科","market":"上櫃","industry":"生技醫療","date":"2026-06-01","time":"13:52:52","subject":"公告本公司董事會推選董事長","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：生華科（6492），2026-06-01 13:52，「公告本公司董事會推選董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6492-2026-06-01-1349-ss0ao7","company_id":"6492","company":"生華科","market":"上櫃","industry":"生技醫療","date":"2026-06-01","time":"13:49:51","subject":"公告本公司股東常會通過解除董事及其代表人競業禁止之限制","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：生華科（6492），2026-06-01 13:49，「公告本公司股東常會通過解除董事及其代表人競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6492-2026-06-01-1344-yl94g7","company_id":"6492","company":"生華科","market":"上櫃","industry":"生技醫療","date":"2026-06-01","time":"13:44:52","subject":"公告本公司115年股東常會全面改選董事選舉結果","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：生華科（6492），2026-06-01 13:44，「公告本公司115年股東常會全面改選董事選舉結果」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6492-2026-06-01-1340-1jb8ii5","company_id":"6492","company":"生華科","market":"上櫃","industry":"生技醫療","date":"2026-06-01","time":"13:40:43","subject":"公告本公司115年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：生華科（6492），2026-06-01 13:40，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4137-2026-06-01-1045-1fqkmsr","company_id":"4137","company":"麗豐-KY","market":"上市","industry":"生技醫療","date":"2026-06-01","time":"10:45:46","subject":"澄清媒體報導","clause":"第51款","fact_date":"2026-06-01","cite_as":"公開資訊觀測站重大訊息：麗豐-KY（4137），2026-06-01 10:45，「澄清媒體報導」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}